New Drug Offers Slim Progress For People With Liver Cancer - Forbes

Forbes

New Drug Offers Slim Progress For People With Liver Cancer Forbes Today the FDA approved a new drug—one of few available—for treating liver cancer. Regorafenib is a pill manufactured by Bayer and sold as Stivarga. Already it's been approved for use in some patients with refractory colon, rectal, and GI stromal tumors. FDA expands approved use of Stivarga to treat liver cancerFDA.gov FDA Approves Regorafenib for Liver CancerOncLive Stivarga Gains FDA Approval for Liver CancerCuretoday.com Healio -Cancer Therapy Advisor all 12 news articles »

from Health - Google News http://ift.tt/2qcP7Qy